418 results on '"Jimenez-Shahed, Joohi"'
Search Results
2. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”
3. Interactive mobile application for Parkinsons disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial.
4. Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort
5. Stereotypies in Childhood Developmental Disorders and Neurodegenerative Diseases
6. Exploring DBS Outcomes in Dystonia (P8-3.005)
7. Multidisciplinary and Telemedicine Pre-operative Evaluations for Deep Brain Stimulation Candidates (P1-3.004)
8. Wearable-based Mediation State Detection in Individuals with Parkinson's Disease
9. Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint
10. Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
11. Managing Deep Brain Stimulation Patients with Tourette Syndrome and Other Emerging Applications
12. Multi-Shared-Task Self-Supervised CNN-LSTM for Monitoring Free-Body Movement UPDRS-III Using Wearable Sensors.
13. Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study.
14. Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank
15. Network oscillatory activity in chronic tics and Tourette syndrome
16. Is essential tremor a disorder of GABA dysfunction? No
17. Hope vs. Hype III: Rescue/on-demand therapies are preferable to device-assisted therapies in Parkinson disease
18. North American survey on impact of the COVID-19 pandemic shutdown on DBS care
19. Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
20. Awake Testing to Confirm Target Engagement
21. Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information
22. National randomized controlled trial of virtual house calls for Parkinson disease
23. Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank.
24. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis
25. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers
26. Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.
27. 26 Correlates of Neuropsychological Decline Following Deep Brain Stimulation in Patients with Parkinson's Disease
28. Ensemble deep model for continuous estimation of Unified Parkinson’s Disease Rating Scale III
29. Dyskinesia estimation during activities of daily living using wearable motion sensors and deep recurrent networks
30. Assessment of response to medication in individuals with Parkinson’s disease
31. Chronic Neurologic Effects of Alcohol
32. Neurologistsʼ Attitudes Toward Use and Timing of Deep Brain Stimulation
33. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit
34. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
35. Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study
36. Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson’s disease
37. Globus Pallidus Interna Stimulation–Induced Gait Disturbance and Management by Reprogramming
38. Open Circuits and Loss of Deep Brain Stimulation Benefit in the Setting of Parkinson Disease
39. Rebound Tremor Following a Suboptimally Placed Ventral Intermediate Nucleus Deep Brain Stimulation
40. VMAT2 Inhibitors in Neuropsychiatric Disorders
41. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort
42. A Single-Center Experience with Local Field Potential-Guided Initial Deep Brain Stimulation Programming in Parkinson’s Disease (P4-11.005)
43. White matter connectivity of subthalamic nucleus and globus pallidus interna targets for deep brain stimulation
44. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
45. Treatment-refractory Tourette Syndrome
46. Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial
47. Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs
48. Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development
49. Deep Brain Stimulation as an Exclusion Criterion in Parkinson's Disease Studies: Time to Rethink?
50. Incremental Learning in Time-series Data using Reinforcement Learning
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.